2.10 USD
↘ 0.06 (2.78%)PRE MARKET (AS OF 05:59 PM EDT)
Pluri Inc. Common Stock
PLURNASDAQ • USD
Market: OPEN
Shares of Pluri Inc. Common Stock (PLUR) are trading at $2.10. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (140.5%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 25, 2026.
Open?$2.12
High?$2.17
Low?$2.06
Prev. Close?$2.16
Volume?5.9K
Avg. Volume?15.5K
VWAP?$2.12
Rel. Volume?0.38x
Bid / Ask
Bid?$1.78 × 100
Ask?$2.48 × 100
Spread?$0.70
Midpoint?$2.13
Valuation & Ratios
Market Cap?23.3M
Shares Out?10.8M
Float?6.1M
Float %?56.1%
P/E Ratio?N/A
P/B Ratio?-1.28
EPS?-$2.37
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Themes
Employees
142
Market Cap
22.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1991-10-09
Address
MATAM ADVANCED TECHNOLOGY PARK
HAIFA,
Phone: 972-74-710-7171
HAIFA,
Phone: 972-74-710-7171
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?10
Short Sent.?75
Piotroski F-Score?3/9Weak
Altman Z-Score?-28.67Distress
Confidence?48%Low
Short InterestLow
Short % of Float?0.28%Low
Short Interest?16.9K
Days to Cover?1.4
Free Float6.1M
Avg Daily Volume12.3K
Settlement Date2026-06-15
Financial Health
Current Ratio?0.32Weak
Quick Ratio?0.32Weak
Cash Ratio?0.11Low
Debt/Equity?-1.51Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-1.28CHEAP▾
S&P97
P/S?21.60HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.9CHEAP▾
S&P97
EV/Sales?43.84HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?140.5%STRONG▾
Peers50
S&P97
ROA?-98.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-22036000
Enterprise Value?$47.3M
Fundamentals ratios updated end of day